4.1 Article

The societal economic value of COVID-19 vaccines in the United States

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Katherine A. Twohig et al.

Summary: A study in England found that patients with COVID-19 infected with the delta variant were more likely to be admitted to hospital or attend emergency care compared to those infected with the alpha variant. This suggests that outbreaks of the delta variant in unvaccinated populations may pose a greater burden on healthcare services.

LANCET INFECTIOUS DISEASES (2022)

Article Economics

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

Paul E. Greenberg et al.

Summary: The number of US adults with major depressive disorder (MDD) increased by 12.9% between 2010 and 2018, resulting in a 37.9% increase in the economic burden. The largest growth in costs was observed in workplace costs. Despite the overall increase in the number of MDD patients, the direct cost per individual decreased, and the proportion of treated patients remained stable, indicating unmet treatment needs. Further research into MDD treatment services is warranted.

PHARMACOECONOMICS (2021)

Article Public, Environmental & Occupational Health

The Societal Value of Vaccination in the Age of COVID-19

David E. Bloom et al.

Summary: Recently, scholars and policymakers have started to realize that the value of vaccines extends beyond health benefits to encompass economic and social welfare. The COVID-19 pandemic has highlighted the significant harms infectious diseases can inflict on society, potentially leading policymakers to take into account the broader societal impacts of vaccination.

AMERICAN JOURNAL OF PUBLIC HEALTH (2021)

Article Multidisciplinary Sciences

The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States

James Broughel et al.

Summary: This paper estimates that the state suppression policies implemented during the initial outbreak of COVID-19 in the United States had positive net benefits to slow the spread of the virus, despite causing some economic output loss.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys

Nicholas J. Irons et al.

Summary: Various data sources provide information on SARS-CoV-2 infection numbers, but they have biases and reporting delays. Representative surveys are limited and crucial for understanding virus spread and intervention effectiveness. A research team develops a Bayesian framework combining multiple data sources to estimate viral prevalence, revealing the underestimation of true infection counts and the implications of progress towards herd immunity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Psychology, Clinical

Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies

Juan Bueno-Notivol et al.

Summary: This paper systematically reviewed community-based studies on depression during the COVID-19 pandemic and estimated a pooled prevalence of 25%. The results suggest a significant impact of the COVID-19 outbreak on people's mental health, indicating the need to prioritize mental health in the international and national public health agenda to enhance citizens' wellbeing.

INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY (2021)

Review Immunology

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence

Nina Vindegaard et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Article Health Care Sciences & Services

The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States

Sarah M. Bartsch et al.

HEALTH AFFAIRS (2020)

Article Health Care Sciences & Services

Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States

Anirban Basu

HEALTH AFFAIRS (2020)

Article Public, Environmental & Occupational Health

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Sarah M. Bartsch et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)

Editorial Material Medicine, General & Internal

The COVID-19 Pandemic and the $16 Trillion Virus

David M. Cutler et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Excess Deaths From COVID-19 and Other Causes, March-July 2020

Steven H. Woolf et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Public, Environmental & Occupational Health

Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity — United States, January 26–October 3, 2020

Lauren M. Rossen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Medicine, General & Internal

Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic

Catherine K. Ettman et al.

JAMA NETWORK OPEN (2020)

Article Multidisciplinary Sciences

Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O'Driscoll et al.

NATURE (2020)

Article Economics

The Benefits and Costs of Using Social Distancing to Flatten the Curve for COVID-19

Linda Thunstrom et al.

JOURNAL OF BENEFIT-COST ANALYSIS (2020)

Article Economics

Age Differences in the Value of Statistical Life: Revealed Preference Evidence

Joseph E. Aldy et al.

REVIEW OF ENVIRONMENTAL ECONOMICS AND POLICY (2007)